Back
Summit Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
SMMT
Summit Therapeutics, Inc.
Last Price:
$14.95
Seasonality Move:
11.06%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight selling pressure.
Summit Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.79 | Buy |
| 20-day SMA: | 15.44 | Sell |
| 50-day SMA: | 16.91 | Sell |
| 200-day SMA: | 20.98 | Sell |
| 8-day EMA: | 13.92 | Buy |
| 20-day EMA: | 9.85 | Buy |
| 50-day EMA: | 5.24 | Buy |
| 200-day EMA: | 1.53 | Buy |
Summit Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.03 | Buy |
| Relative Strength Index (14 RSI): | 43.21 | Sell |
| Chaikin Money Flow: | -770060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.54 - 17.24) | Sell |
| Bollinger Bands (100): | (16.06 - 20.24) | Sell |
Summit Therapeutics, Inc. Technical Analysis
| Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics, Inc. Stock
Is Summit Therapeutics, Inc. Stock a Buy?
-
Summit Therapeutics, Inc. share price is 14.96 while SMMT 8-day simple moving average is 14.79, which is a Buy signal.
-
The stock price of SMMT is 14.96 while Summit Therapeutics, Inc. 20-day SMA is 15.44, which makes it a Sell.
-
Summit Therapeutics, Inc. 50-day simple moving average is 16.91 while SMMT share price is 14.96, making it a Sell technically.
-
SMMT stock price is 14.96 and Summit Therapeutics, Inc. 200-day simple moving average is 20.98, creating a Sell signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
34
Summit Therapeutics, Inc. (SMMT)
is a Sell
Is Summit Therapeutics, Inc. a Buy or a Sell?
-
Summit Therapeutics, Inc. stock is rated a SellThe current Summit Therapeutics, Inc. [SMMT] share price is $14.96. The Score for SMMT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics, Inc. Stock Info
Market Cap:
11.1B
Price in USD:
14.96
Share Volume:
2.2M
Summit Therapeutics, Inc. 52-Week Range
52-Week High:
36.91
52-Week Low:
13.83
Sell
34
Summit Therapeutics, Inc. (SMMT)
is a Sell
Summit Therapeutics, Inc. Share Price Forecast
-
What is the Summit Therapeutics, Inc. stock price today?The Summit Therapeutics, Inc. stock price is 14.96 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics, Inc. is overvalued.
Is Summit Therapeutics, Inc. Stock a Buy?
-
Summit Therapeutics, Inc. share price is 14.96 while SMMT 8-day exponential moving average is 13.92, which is a Buy signal.
-
The stock price of SMMT is 14.96 while Summit Therapeutics, Inc. 20-day EMA is 9.85, which makes it a Buy.
-
Summit Therapeutics, Inc. 50-day exponential moving average is 5.24 while SMMT share price is 14.96, making it a Buy technically.
-
SMMT stock price is 14.96 and Summit Therapeutics, Inc. 200-day simple moving average is 1.53, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics, Inc.
Is Summit Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.13 per share.
Technical Analysis of Summit Therapeutics, Inc.
Should I short Summit Therapeutics, Inc. stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 4.03, suggesting Summit Therapeutics, Inc. is a Buy
-
Summit Therapeutics, Inc. Relative Strength Index (RSI) is 43.21, which suggest Summit Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Summit Therapeutics, Inc. is (14.54 - 17.24), which suggest Summit Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Summit Therapeutics, Inc. is (16.06 - 20.24), which suggest Summit Therapeutics, Inc. is a Sell
* Summit Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.